ZEAL:CPH
Zealand Pharma A/S
DKK 238.00
arrow_upward
+0.42%(+1.00) 1D
10-р сарын 9, 17:00:00 (GMT+2) · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKK 240.00
High
DKK 241.70
Low
DKK 236.00
Mkt. cap
16.97 тэрбум
Avg. vol.
412.72 мян
Volume
293.77 мян
52-wk high
DKK 556.00
52-wk low
DKK 233.50
Shares outstanding
71.61 сая
No. of employees
578
Open
DKK 240.00
High
DKK 241.70
Low
DKK 236.00
Mkt. cap
16.97 тэрбум
Avg. vol.
412.72 мян
Volume
293.77 мян
52-wk high
DKK 556.00
52-wk low
DKK 233.50
Shares outstanding
71.61 сая
No. of employees
578
News stories
From web sources and news partners
TipRanks
·
2 өдрийн өмнө
Zealand Pharma Advances Petrelintide Into Phase III, Raising Its Profile in the Obesity Drug Race
TipRanks
·
2 өдрийн өмнө
Petrelintide Phase III Trial Puts Zealand Pharma in the Obesity–Heart Disease Spotlight
TipRanks
·
4 долоо хоногийн өмнө
Petrelintide Phase III Trial Puts Zealand Pharma in the Weight-Loss Spotlight
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
Founded1997 оны 4-р сарын 1
Headquarters-
Sector-
Websitezealandpharma.com